Effects of Low Doses of Ketamine on Pyramidal Neurons in Rat Prefrontal Cortex. (1st August 2018)

• Record Type: Journal Article
• Authors: Shen, Guofang; Han, Feng; Shi, Wei-Xing
• Is Part Of: Neuroscience. Volume 384(2018)
• Page Start: 178
• Page End: 187
• Publication Date: 2018-08-01
• Subjects: AMPA α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid -- DA dopamine -- FFT fast Fourier transform -- GABA γ-aminobutyric acid -- HT Hilbert transform -- ISI interspike interval -- LFP local field potential -- NMDA N-methyl-d-aspartate -- NR2B N-methyl d-aspartate receptor subtype 2B -- PCP phencyclidine -- PFC prefrontal cortex -- PS Poisson surprise method -- Ro25 Ro25-6981 -- SO slow oscillation -- STA spike-triggered average; ketamine -- prefrontal cortex -- single-unit recording -- local field potential -- NMDA receptor -- NR2B; Neurochemistry -- Periodicals; Neurophysiology -- Periodicals; Neurology -- Periodicals; Neurochimie -- Périodiques; Neurophysiologie -- Périodiques; Neurochemistry; Neurophysiology; Electronic journals; Periodicals; Electronic journals; 612.8
• DOI: 10.1016/j.neuroscience.2018.05.037
• Languages: English
• ISSNs: 0306-4522

Abstract

Highlights: Simultaneous single-unit and local-field-potential recordings were made from the PFC in chloral hydrate-anesthetized rats. Ketamine (1.25–20 mg/kg, i.v.) inhibited most pyramidal neurons tested and consistently suppressed PFC UP state. MK801, but not the NR2B-selective NMDA receptor antagonist Ro25-6981, mimicked the effect of ketamine. The effect of ketamine persisted in the presence of D2, GABAA, or GABAB receptor blockade. Abstract: Indirect evidence suggests that low doses of ketamine disinhibit (excite) pyramidal neurons in the prefrontal cortex (PFC). In this study, we directly examined the effect of ketamine on PFC pyramidal neurons using simultaneous single-cell and local-field-potential (LFP) recording in chloral hydrate-anesthetized rats. In all animals studied, PFC LFPs showed oscillations (0.3–1.5 Hz) between the active UP state and the relatively quiescent DOWN state, and pyramidal neurons fired preferentially during the UP state. Ketamine (1.25–20 mg/kg, i.v.) inhibited 80% of cells tested and consistently shifted PFC LFPs toward the DOWN state. The inhibitory effect of ketamine was mimicked by MK801, but not by the NR2B-selective NMDA receptor antagonist Ro25-6981. It was not blocked by the dopamine receptor antagonist fluphenazine, the GABAA receptor antagonist picrotoxinin, or the GABAB receptor antagonist CGP46381. These results are consistent with the high density of NMDA receptors expressed on PFC pyramidal neurons and our previous studies showing that blockade of NMDA receptors by ketamine inhibits dendritic NMDA receptor-mediated bursting in PFC pyramidal neurons. Thus, in addition to the previously proposed disinhibitory effect mediated through PFC interneurons, our data suggest that ketamine has an inhibitory effect on PFC pyramidal neurons. Our evidence further suggests that the effect is mediated through non-NR2B-containing NMDA receptors, independent of ketamine's effect on dopamine and GABA transmission. Further understanding of the two opposing effects of ketamine on PFC pyramidal neurons may provide important new insights into its mechanism of action.